ES480113A1 - Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina. - Google Patents

Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.

Info

Publication number
ES480113A1
ES480113A1 ES480113A ES480113A ES480113A1 ES 480113 A1 ES480113 A1 ES 480113A1 ES 480113 A ES480113 A ES 480113A ES 480113 A ES480113 A ES 480113A ES 480113 A1 ES480113 A1 ES 480113A1
Authority
ES
Spain
Prior art keywords
imino
imidazolidine
derivatives
intermediates
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480113A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES480113A1 publication Critical patent/ES480113A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Procedimiento para la preparación de nuevos derivados de 2- iminoimidazolidina los productos del procedimiento y sus sales aceptables en farmacia pueden utilizarse como medicamentos, or ejemplo en forma de preparados farmacéuticos que los contengan o sus sales, en mezcla con un material de vehículo inerte y farmacéutico, orgánico o inorgánico, apto para administración enteral o parental tal como, por ejemplo, agua, gelatina, goma arábiga, lactosa, almidón, estearato de magnesio, talco, aceites vegetales, polialquilenglicoles, vaselina, etc. los preparados farmacéuticos pueden adoptar forma sólida, por ejemplo de pastillas, gráficas supositorios o capsulas, o forma líquida, por ejemplo de soluciones suspensiones o emulsiones. Puedes opcionalmente, esterilizarse y/o contener coadyuvantes o emulgentes sales para modificar la presión osmótica o tampones. Adicionalmente pueden contener también otras sustancias terapéuticamente valiosas.
ES480113A 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina. Expired ES480113A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78467 1977-11-07
CH966878 1978-09-15

Publications (1)

Publication Number Publication Date
ES480113A1 true ES480113A1 (es) 1980-04-01

Family

ID=25705131

Family Applications (3)

Application Number Title Priority Date Filing Date
ES480112A Expired ES480112A1 (es) 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES480111A Expired ES480111A1 (es) 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES480113A Expired ES480113A1 (es) 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES480112A Expired ES480112A1 (es) 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES480111A Expired ES480111A1 (es) 1977-11-07 1979-04-30 Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.

Country Status (30)

Country Link
US (3) US4244957A (es)
EP (1) EP0002010B1 (es)
JP (1) JPS5473779A (es)
AR (1) AR223656A1 (es)
AT (1) AT371112B (es)
AU (1) AU4132478A (es)
BR (1) BR7807317A (es)
CA (1) CA1106847A (es)
CS (1) CS212309B2 (es)
DD (1) DD139847A5 (es)
DE (2) DE2847766A1 (es)
DK (1) DK494978A (es)
EG (1) EG13665A (es)
ES (3) ES480112A1 (es)
FI (1) FI783393A (es)
FR (1) FR2407919A1 (es)
GB (2) GB2008579B (es)
IL (1) IL55832A0 (es)
IT (1) IT1160046B (es)
MC (1) MC1223A1 (es)
MT (1) MTP837B (es)
NL (1) NL7811070A (es)
NO (1) NO783719L (es)
NZ (1) NZ188798A (es)
OA (1) OA06084A (es)
PL (1) PL210759A1 (es)
PT (1) PT68752A (es)
RO (1) RO76151A (es)
SE (1) SE7811455L (es)
SU (2) SU831073A3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287201A (en) * 1980-03-03 1981-09-01 Merck & Co., Inc. Anovulatory method and chicken feed compositions
CA1175434A (en) * 1980-09-10 1984-10-02 Hoffmann-La Roche Limited ¬(2-phenylamino-1-imidazolidinyloxy)methyl| pyridine 1-oxide derivatives
DE3642453A1 (de) * 1986-12-12 1988-06-23 Bayer Ag Neue, fluor enthaltende 5-trihalogenmethyl-isoxazole und ein verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO2002004421A2 (en) * 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
GB2374251A (en) * 2001-04-04 2002-10-09 Secr Defence Base station transmitter
WO2003042193A1 (en) * 2001-11-09 2003-05-22 Geneva Pharmaceuticals, Inc. Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide
US6703409B2 (en) 2002-01-31 2004-03-09 Boehringer Ingelheim Pharma Gmbh & Co Kg 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
EP1333028A1 (en) * 2002-01-31 2003-08-06 Boehringer Ingelheim Pharma GmbH & Co.KG 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
AU2009282747B2 (en) 2008-08-22 2015-04-02 Takeda Pharmaceutical Company Limited Polymeric benzyl carbonate-derivatives

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670274U (de) 1953-07-30 1954-01-14 Leo Schirk Stahlblechschalttafel.
DE1815788U (de) 1959-12-12 1960-07-28 Walther Loeffler Ventil fuer spuelbecken, waschbecken, bidets, wannen.
US3236857A (en) 1961-10-09 1966-02-22 Boehringer Sohn Ingelheim 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
NL123037C (es) 1963-10-04
DE1545628A1 (de) 1965-10-01 1970-06-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2)
DE1670274A1 (de) * 1966-10-31 1970-07-16 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von 2-Arylamino-1,3-diazacycloalkenen-(2)
DE1670230A1 (de) 1967-05-26 1971-01-21 Boehringer Sohn Ingelheim Neues Verfahren zur Herstellung von in 2-Stellung substituierten 1,3-Diazacycloalkenen(2)
ES352379A1 (es) 1967-05-26 1969-08-01 Boehringer Sohn Ingelheim Procedimiento para la preparacion de 1,3-diazaciclopenteno-(2) sustituido en posicion 2.
US3454301A (en) * 1967-09-29 1969-07-08 John W Lehmann Glare-inhibiting device
GB1246312A (en) * 1968-01-10 1971-09-15 Syntex Energy Res Inc 4,5-substituted n-oxy and hydroxy hydroimidazoles
DE1770872A1 (de) 1968-08-26 1972-01-13 Dresden Arzneimittel Verfahren zur Herstellung von Imidazolin-2-Derivaten
BE721781A (es) 1968-10-03 1969-04-03
BE759048A (fr) * 1969-11-17 1971-05-17 Boehringer Sohn Ingelheim Nouvelles n-aminoalcoyl-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE2016290A1 (de) * 1970-04-06 1971-11-04 C H Boehrmger Sohn, 6507 Ingel heim Substituierte N Hydroxylakyl 2 arylamine) imidazoline (2) und Verfahren zu deren Herstellung
US3740412A (en) * 1970-04-08 1973-06-19 Synvar Ass Imidazoline-3-oxide-1-oxyl derivatives
DE2038107A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Fluessige,gegebenenfalls als Wasch- oder Reinigungsmittel brauchbare stabilisierte Enzympraeparate
US3799942A (en) * 1971-04-12 1974-03-26 Syva Corp 4,5-substituted n-oxy and hydroxy hydroimidazoles
BE787477A (fr) * 1971-08-12 1973-02-12 Bayer Ag 1-phenyl-2-imino-imidazolidines, leur procede de preparation etleur application comme repulsifs a l'egard des oiseaux
DE2457979A1 (de) 1974-12-07 1976-06-16 Beiersdorf Ag 2-n-aryl-hydroxyamino-imidazoline-(2) und verfahren zu deren herstellung
DE2523103C3 (de) * 1975-05-24 1979-11-29 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte 2-[N-Progargyl-N-(2-chlorphenyl)amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung
AT339897B (de) * 1975-09-25 1977-11-10 Chemie Linz Ag Verfahren zur herstellung des neuen 1-benzoyl-2- (2',6'-dichlorphenylamino) -2-imidazolins und von dessen salzen
DE2626128A1 (de) * 1976-06-11 1977-12-22 Beiersdorf Ag N-substituierte benzimidazolin-2-one und verfahren zu deren herstellung
DE2709720A1 (de) * 1977-03-05 1978-09-07 Beiersdorf Ag N-substituierte 2-arylamino-imidazoline-(2), verfahren zu deren herstellung und neue hydroxylamine als zwischenprodukte
US4131679A (en) * 1977-07-26 1978-12-26 Sandoz, Inc. Substituted 4-hydroxy pyridones
DE2811847A1 (de) * 1978-03-17 1979-09-20 Lentia Gmbh Neue arylaminoimidazolinderivate, deren herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
SU910119A3 (ru) 1982-02-28
DD139847A5 (de) 1980-01-23
CS212309B2 (en) 1982-03-26
NZ188798A (en) 1981-04-24
MTP837B (en) 1979-10-22
FR2407919A1 (fr) 1979-06-01
PT68752A (en) 1978-12-01
SE7811455L (sv) 1979-07-02
GB2008579A (en) 1979-06-06
AR223656A1 (es) 1981-09-15
ES480111A1 (es) 1980-04-01
DE2847766A1 (de) 1979-05-10
IL55832A0 (en) 1978-12-17
NO783719L (no) 1979-05-08
SU831073A3 (ru) 1981-05-15
MC1223A1 (fr) 1979-07-20
US4511720A (en) 1985-04-16
IT7829486A0 (it) 1978-11-06
BR7807317A (pt) 1979-07-24
AU4132478A (en) 1979-05-17
NL7811070A (nl) 1979-05-09
JPS5473779A (en) 1979-06-13
FI783393A (fi) 1979-05-08
GB2086379A (en) 1982-05-12
US4244957A (en) 1981-01-13
DE2861952D1 (en) 1982-09-02
EP0002010A1 (de) 1979-05-30
DK494978A (da) 1979-05-08
GB2008579B (en) 1982-11-03
EG13665A (en) 1982-03-31
ES480112A1 (es) 1980-04-01
IT1160046B (it) 1987-03-04
CA1106847A (en) 1981-08-11
US4355033A (en) 1982-10-19
PL210759A1 (es) 1980-03-10
ATA791378A (de) 1982-10-15
GB2086379B (en) 1982-11-10
AT371112B (de) 1983-06-10
RO76151A (ro) 1981-08-30
OA06084A (fr) 1981-06-30
EP0002010B1 (de) 1982-07-14

Similar Documents

Publication Publication Date Title
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES8202799A1 (es) Procedimiento para la preparacion de sulfonilureas
ES480114A1 (es) Procedimiento para la preparacion de derivados de imidazoli-dina.
DE3167320D1 (en) Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same
ES476109A1 (es) Procedimiento para la preparacion de derivados de cefalospo-rina
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
ES8107216A1 (es) Procedimiento para la preparacion de sulfonilureas
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8404852A1 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
ES8105991A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES8305342A1 (es) "procedimiento para la preparacion de derivados de tiazolina".
ES439261A1 (es) Procedimiento para preparar acido 5-(2-hidroxi-n-propoxi)-4-oxo-8-n-propil-4h-1-benzopiran-2-carboxilico.
ES8200684A1 (es) Procedimiento para la preparacion de sulfonilureas
ES464773A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos.
ES469426A1 (es) Un procedimiento para la preparacion de derivados n-al- quil-n-iminometilicos de tienamicina
ES473909A1 (es) Procedimiento para la obtencion de derivados del acido ci- clohexil-4 naftaleno-acetico-1